LSI vs STOK
LSI (LSI) versus Stoke Therapeutics Inc (STOK) — a side-by-side from cached financials, not a winner call.
LSI (LSI) common stock.
Stoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
LSI does not have a complete income-statement cache yet.
Latest reported STOK revenue for 2026-06-30 was $15.6M. Net income was -$111.6M. STOK currently screens at market cap $1.88B.
STOK currently screens at market cap $1.88B.
Not investment advice. Open the LSI and STOK stock pages for the full models.
Not investment advice.